Primary effusion lymphoma (PEL) is a human herpes virus 8 (HHV8)-positive large B-cell neoplasm that presents as an effusion with no detectable tumor in individuals with human immunodeficiency virus infection or other immune deficiencies. PEL is an aggressive neoplasm with a poor prognosis. PEL cells show diverse morphologies, ranging from immunoblastic or plasmablastic to anaplastic. The immunophenotype of PEL is distinct, but its lineage can be misdiagnosed if not assessed thoroughly. PEL cells usually express CD45, lack B- and T-cell-associated antigens, and characteristically express lymphocyte activation antigens and plasma cell-associated antigens. Diagnosis of PEL often requires the demonstration of a B-cell genotype. HHV8 must be detected in cells to diagnose PEL. In most cases, PEL cells also harbor the Epstein-Barr virus (EBV) genome. Similar conditions associated with HHV8 but not effusion-based are called "extracavitary PELs." PELs should be differentiated from HHV8-negative, EBV-positive, body cavity-based lymphomas in patients with long-standing chronic inflammation; the latter can occur in tuberculous pleuritis, artificial pneumothorax, chronic liver disease and various other conditions. Despite their morphological similarity, these various lymphomas require different therapeutic strategies and have different prognostic implications. Correct diagnosis is essential to manage and predict the outcome of patients with PEL and related disorders.

Citations

Citations to this article as recorded by  

• Oncolytic strategy using new bifunctional HDACs/BRD4 inhibitors against virus-associated lymphomas
  Jungang Chen, Zhengyu Wang, Tran Phuc, Zhigang Xu, Donglin Yang, Zhengzhu Chen, Zhen Lin, Samantha Kendrick, Lu Dai, Hong-yu Li, Zhiqiang Qin, Michael Lagunoff
  PLOS Pathogens.2023; 19(1): e1011089.     CrossRef
• Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV
  Chih-Yi Liu, Bo-Jung Chen, Shih-Sung Chuang
  Diagnostics.2022; 12(3): 713.     CrossRef
• Lymphoproliferative disorder involving body fluid: diagnostic approaches and roles of ancillary studies
  Jiwon Koh, Sun Ah Shin, Ji Ae Lee, Yoon Kyung Jeon
  Journal of Pathology and Translational Medicine.2022; 56(4): 173.     CrossRef
• Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review
  Jelena Jelicic, Thomas Stauffer Larsen, Annette Dam Fialla, Zoran Bukumiric, Bosko Andjelic
  Clinical Lymphoma Myeloma and Leukemia.2022; 22(11): e981.     CrossRef
• HHV8-unrelated primary effusion lymphoma: Two case reports and a review of literature
  Ryan W. Kendall, Ricky A. Thompson, Christopher P. Garwacki, Alan Z. Skarbnik
  Current Problems in Cancer: Case Reports.2021; 4: 100087.     CrossRef
• Targeting Host Cellular Factors as a Strategy of Therapeutic Intervention for Herpesvirus Infections
  Kumari Asha, Neelam Sharma-Walia
  Frontiers in Cellular and Infection Microbiology.2021;[Epub]     CrossRef
• A Rare Case of Extracavitary Primary Effusion Lymphoma in the Bladder and Ureter
  Jiankun Tong, Sana Jadallah, William H. Rodgers, Gabriel Jung, Malvina Fulman, Abhisek Swaika
  Case Reports in Hematology.2020; 2020: 1.     CrossRef
• KSHV: Immune Modulation and Immunotherapy
  Grant Broussard, Blossom Damania
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Role of Ki 67 Labelling Index as an Adjunct to Histopathological Diagnosis for Grading of CNS Tumours
  Priyanka Rai, Chandni Krishnani, Goswami S. S.
  Journal of Evolution of Medical and Dental Sciences.2020; 9(16): 1331.     CrossRef
• Brentuximab vedotin as frontline treatment for HIV-related extracavitary primary effusion lymphoma
  Jose D. Sandoval-Sus, Amanda Brahim, Alina Khan, Barbara Raphael, Ali Ansari-Lari, Marco Ruiz
  International Journal of Hematology.2019; 109(5): 622.     CrossRef
• High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion Lymphoma
  Abu-Sayeef Mirza, Bhagirathbhai R. Dholaria, Mohammad Hussaini, Sarah Mushtaq, Pedro Horna, Adharsh Ravindran, Ambuj Kumar, Ernesto Ayala, Mohamed A. Kharfan-Dabaja, Celeste Bello, Julio C. Chavez, Lubomir Sokol
  Clinical Lymphoma Myeloma and Leukemia.2019; 19(9): e513.     CrossRef
• Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir
  Laura Campogiani, Carlotta Cerva, Gaetano Maffongelli, Elisabetta Teti, Livio Pupo, Sara Vaccarini, Maria Cantonetti, Alfredo Pennica, Massimo Andreoni, Loredana Sarmati
  AIDS Research and Therapy.2019;[Epub]     CrossRef
• Primary Effusion Lymphoma in a Non-Human Immunodeficiency Virus Patient: A Case Report
  Beum Jin Kim, Mi Sook Lee
  Journal of the Korean Society of Radiology.2019; 80(4): 810.     CrossRef
• Pleural effusion in a human immunodeficiency virus‐infected patient
  Rafael Martínez‐Girón, Santiago Martínez‐Torre
  Cytopathology.2019; 30(6): 673.     CrossRef
• Case report of a primary effusion lymphoma successfully treated with oral valganciclovir after failing chemotherapy
  Juan Marquet, Kyra Velazquez-Kennedy, Sandra López, Amparo Benito, María-Jesús Blanchard, Jose Antonio Garcia-Vela
  Hematological Oncology.2018; 36(1): 316.     CrossRef
• Primary effusion lymphoma in Taiwan shows two distinctive clinicopathological subtypes with rare human immunodeficiency virus association
  Bo-Jung Chen, Ran-Ching Wang, Chung-Han Ho, Chang-Tsu Yuan, Wan-Ting Huang, Sheau-Fang Yang, Pin-Pen Hsieh, Yun-Chih Yung, Shih-Yao Lin, Chen-Fang Hsu, Ying-Zhen Su, Chun-Chi Kuo, Shih-Sung Chuang
  Histopathology.2018; 72(6): 930.     CrossRef
• Effusion-based lymphoma with morphological regression but with clonal genetic features after aspiration
  Meng-Chen Tsai, Chun-Chi Kuo, Ying-Zhen Su, Yen-Chuan Hsieh, Shih-Sung Chuang
  Diagnostic Cytopathology.2018; 46(8): 685.     CrossRef
• Biology and management of primary effusion lymphoma
  Kazuyuki Shimada, Fumihiko Hayakawa, Hitoshi Kiyoi
  Blood.2018; 132(18): 1879.     CrossRef
• EBV-associated but HHV8-unrelated double-hit effusion-based lymphoma
  Bo-Jung Chen, David Yen-Ting Chen, Chun-Chi Kuo, Shih-Sung Chuang
  Diagnostic Cytopathology.2017; 45(3): 257.     CrossRef
• HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms
  Amy Chadburn, Jonathan Said, Dita Gratzinger, John K. C. Chan, Daphne de Jong, Elaine S. Jaffe, Yasodha Natkunam, John R. Goodlad
  American Journal of Clinical Pathology.2017; 147(2): 171.     CrossRef
• Human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV) related lymphomas, pathology view point
  Ebru Linke-Serinsöz, Falko Fend, Leticia Quintanilla-Martinez
  Seminars in Diagnostic Pathology.2017; 34(4): 352.     CrossRef
• Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach
  D. Belletti, G. Riva, M. Luppi, G. Tosi, F. Forni, M.A. Vandelli, B. Ruozi, F. Pederzoli
  European Journal of Pharmaceutical Sciences.2017; 107: 230.     CrossRef
• CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases
  Jing Li, Shu Zhao, Jingxuan Wang, Jingyu Chen, Wen Wen, Qingyuan Zhang
  Tumor Biology.2016; 37(3): 3619.     CrossRef
• Co-infections and Pathogenesis of KSHV-Associated Malignancies
  Suhani Thakker, Subhash C. Verma
  Frontiers in Microbiology.2016;[Epub]     CrossRef
• Pathology of Extranodal Lymphoma
  Emily Heckendorn, Aaron Auerbach
  Radiologic Clinics of North America.2016; 54(4): 639.     CrossRef
• 2015 update on the diagnosis and management of neoplastic pericardial disease
  Chiara Lestuzzi, Massimiliano Berretta, Witold Tomkowski
  Expert Review of Cardiovascular Therapy.2015; 13(4): 377.     CrossRef
• CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options
  Jorge J Castillo, Julio C Chavez, Francisco J Hernandez-Ilizaliturri, Santiago Montes-Moreno
  Expert Review of Hematology.2015; 8(3): 343.     CrossRef
• Primary Effusion Lymphoma: Cytological Diagnosis of a Rare Entity - Report of Two Cases in HIV-Uninfected Patients from a Single Institution
  Marta Nicola, Monica Onorati, Chiara Luisa Bianchi, Giuseppe Pepe, Stefano Bellone, Franca Di Nuovo
  Acta Cytologica.2015; 59(5): 425.     CrossRef